PETRIOLI, ROBERTO
PETRIOLI, ROBERTO
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis
2016-01-01 De Franco, Lorenzo Giacinto; Marrelli, Daniele; Caputo, Edda; Petrioli, Roberto; Roviello, Giandomenico; Calvanese, A.; Roviello, Franco
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient
2020-01-01 Miano, S. T.; Francini, E.; Petrioli, R.; Francini, G.
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report
2013-01-01 Roviello, Giandomenico; Petrioli, Roberto; Cerase, Alfonso; Marsili, Stefania; Miracco, Clelia; Rubino, Giovanni; Tini, Paolo
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer
2021-01-01 Marrelli, D.; Petrioli, R.; Cassetti, D.; D'Ignazio, A.; Marsili, S.; Mazzei, M. A.; Lazzi, S.; Roviello, F.
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer
2015-01-01 Roviello, Giandomenico; Francini, Edoardo; Perrella, Armando; Laera, Letizia; Mazzei, MARIA ANTONIETTA; Guerrini, Susanna; Petrioli, Roberto
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases
2004-01-01 Petrioli, R.; Rossi, S.; Caniggia, M.; Pozzessere, D.; Messinese, S.; Sabatino, M.; Marsili, S.; Correale, P.; Salvestrini, F.; Manganelli, A.; Francini, G.
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer
2016-01-01 Roviello, Giandomenico; Petrioli, Roberto; Marano, Luigi; Polom, Karol Roman; Marrelli, Daniele; Perrella, Armando; Roviello, Franco
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer
2016-01-01 Roviello, Giandomenico; Ravelli, Andrea; Polom, Karol Roman; Petrioli, Roberto; Marano, Luigi; Marrelli, Daniele; Roviello, Franco; Generali, Daniele
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy
2021-01-01 Francini, E.; Montagnani, F.; Nuzzo, P. V.; Gonzalez-Velez, M.; Alimohamed, N. S.; Rosellini, P.; Moreno-Candilejo, I.; Cigliola, A.; Rubio-Perez, J.; Crivelli, F.; Shaw, G. K.; Zhang, L.; Petrioli, R.; Bengala, C.; Francini, G.; Garcia-Foncillas, J.; Sweeney, C. J.; Higano, C. S.; Bryce, A. H.; Harshman, L. C.; Lee-Ying, R.; Heng, D. Y. C.
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer
2018-01-01 Petrioli, R.; Francini, E.; Cherri, S.; Torre, P.; Fiaschi, A. I.; Miano, S. T.; Marrelli, D.; Rovello, F.; Francini, G.
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab
2012-01-01 Petrioli, Roberto; Licchetta, A.; Roviello, Franco; Pascucci, A.; Francini, E.; Bargagli, G.; Conca, R.; Miano, S. T.; Marzocca, G.; Francini, Guido; Multidisciplinary Oncology Group on Gastrointestinal, Tumors; Savelli, Vinno
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials
2001-01-01 Klijn, J. G. M.; Blamey, R. W.; Boccardo, F.; Tominaga, T.; Duchateau, L.; Sylvester, R.; Beex, L. V. A. M.; Mauriac, L.; Van Zijl, J. A.; Veyret, C.; Wildiers, J.; Jassem, J.; Piccart, M.; Burghouts, J.; Becqaert, D.; Seynaeve, C.; Mignolet, F.; Duchateau, L.; Sylvester, R.; Namer, M.; Julien, J. P.; Garcia Conde, J.; Dunser, M.; Margreiter, R.; Tjabbes, T.; Roozendaal, K. J.; Van der Velden, P. C.; Nortier, J. W. R.; Blamey, R.; Howell, A.; Forbes, J.; Kaufmann, M.; Nordenskjold, B.; Kvinnsland, S.; Wilson, R. G.; Jonat, W.; Kleeberg, U. R.; Eiermann, W.; Hilfrich, J.; Weitzel, H. K.; Glas, U.; Rutqvist, L. E.; Rudenstam, C.; Sander, S.; Ryden, S.; Honsson, P.; Lonning, P. E.; Loven, L.; Russell, I. S.; Olweny, C.; Byrne, J. J.; Snyder, R. D.; Coates, A. S.; Lowenthal, R. M.; Jeal, P. N.; Dalley, D. N.; Janicke, F.; Kleine, W.; Michel, R. Th.; Canobbio, L.; Amoroso, D.; Rubagotti, A.; Bumma, C.; D'Aprile, M.; De Matteis, A.; Di Carlo, A.; Francini, G.; Petrioli, R.; Folco, U.; Calligioni, E.; Gallotti, P.; Lopez, M.; Mesiti, M.; Pacini, P.; Sassi, M.; Sismondi, P.; Zola, P.; Ogita, M.; Okazaki, M.; Watanabe, T.; Satomi, T.; Hatazawa, C.; Okuyama, N.; Koyama, T.; Kobayashi, M.; Shimizu, T.; Tabei, T.; Sano, M.; Makino, H.; Ando, J.; Kimura, M.; Takeuchi, T.; Aoyama, H.; Koyama, H.; Shin, E.; Chou, G.
Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinoma
2024-01-01 Micheletti, Giorgio; Ricchiuti, Vincenzo; Carbone, Ludovico; La Francesca, Noemi; Petrioli, Roberto; Marrelli, Daniele
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy
2018-01-01 Petrioli, Roberto; Chirra, Martina; Messuti, Luciana; Fiaschi, Anna Ida; Savelli, Vinno; Martellucci, Ignazio; Francini, Edoardo
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer
1999-01-01 Erlichman, C; O'Connell, M; Kahn, M; Marsoni, S; Torri, V; Tardio, B; Zaniboni, A; Pancera, G; Martignoni, G; Labianca, R; Barni, A; Seitz, Jf; Milan, C; Bedenne, L; Giovannini, M; Letreut, Yp; Skillings, J; Shepard, L; Zee, B; Petrioli, R; Francini, G
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence
2016-01-01 Polom, Karol Roman; Marano, Luigi; Roviello, Giandomenico; Petrioli, Roberto; Piagnerelli, Riccardo; De Franco, Lorenzo Giacinto; Marrelli, Daniele; Roviello, Franco
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer
2020-01-01 Petrioli, Roberto; Francini, Edoardo; Cherri, Sara; Marrelli, Daniele; Roviello, Franco; Fiaschi, Anna Ida; Miano, Salvatora Tindara; Savelli, Vinno; Calomino, Natale; Farsi, Marco; Vernillo, Remo; Francini, Guido
Gastric cancer: Current status of lymph node dissection
2016-01-01 Degiuli, Maurizio; De Manzoni, Giovanni; Di Leo, Alberto; D'Ugo, Domenico; Galasso, Erica; Marrelli, Daniele; Petrioli, Roberto; Polom, Karol Roman; Roviello, Franco; Santullo, Francesco; Morino, Mario
GEMCITABINE (dFdC), 5-FLUROURACIL (5FU), AND FOLINIC ACID (FA) IN THE TREATMENT OF PATIENTS WITH GASTRO-ENTERIC CARCINOMAS: A CLINICAL AND PHARMACOLOGICAL STUDY.
2000-01-01 Pierpaolo, Correale; Cerretani, Daniela; Maurizia, Clerici; Claudio, Cozzi; Bruni, Giancarlo; Daniele, Pozzessere; Petrioli, Roberto; Marsili, Stefania; Simona, Messinesc; Sabatino, Mananna; Roviello, Franco; Neri, Alessandro; Pinto, Enrico; Giorgi, Giorgio; Francini, Guido
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer
2020-01-01 Petrioli, R.; Torre, P.; Pesola, G.; Paganini, G.; Paolelli, L.; Miano, S. T.; Martellucci, I.; Francini, G.; Francini, E.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| 28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis | 1-gen-2016 | De Franco, Lorenzo Giacinto; Marrelli, Daniele; Caputo, Edda; Petrioli, Roberto; Roviello, Giandomenico; Calvanese, A.; Roviello, Franco | - | |
| A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient | 1-gen-2020 | Miano, S. T.; Francini, E.; Petrioli, R.; Francini, G. | - | |
| A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report | 1-gen-2013 | Roviello, Giandomenico; Petrioli, Roberto; Cerase, Alfonso; Marsili, Stefania; Miracco, Clelia; Rubino, Giovanni; Tini, Paolo | - | |
| A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer | 1-gen-2021 | Marrelli, D.; Petrioli, R.; Cassetti, D.; D'Ignazio, A.; Marsili, S.; Mazzei, M. A.; Lazzi, S.; Roviello, F. | - | |
| An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer | 1-gen-2015 | Roviello, Giandomenico; Francini, Edoardo; Perrella, Armando; Laera, Letizia; Mazzei, MARIA ANTONIETTA; Guerrini, Susanna; Petrioli, Roberto | - | |
| Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases | 1-gen-2004 | Petrioli, R.; Rossi, S.; Caniggia, M.; Pozzessere, D.; Messinese, S.; Sabatino, M.; Marsili, S.; Correale, P.; Salvestrini, F.; Manganelli, A.; Francini, G. | - | |
| Angiogenesis inhibitors in gastric and gastroesophageal junction cancer | 1-gen-2016 | Roviello, Giandomenico; Petrioli, Roberto; Marano, Luigi; Polom, Karol Roman; Marrelli, Daniele; Perrella, Armando; Roviello, Franco | - | |
| Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer | 1-gen-2016 | Roviello, Giandomenico; Ravelli, Andrea; Polom, Karol Roman; Petrioli, Roberto; Marano, Luigi; Marrelli, Daniele; Roviello, Franco; Generali, Daniele | - | |
| Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy | 1-gen-2021 | Francini, E.; Montagnani, F.; Nuzzo, P. V.; Gonzalez-Velez, M.; Alimohamed, N. S.; Rosellini, P.; Moreno-Candilejo, I.; Cigliola, A.; Rubio-Perez, J.; Crivelli, F.; Shaw, G. K.; Zhang, L.; Petrioli, R.; Bengala, C.; Francini, G.; Garcia-Foncillas, J.; Sweeney, C. J.; Higano, C. S.; Bryce, A. H.; Harshman, L. C.; Lee-Ying, R.; Heng, D. Y. C. | - | |
| Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer | 1-gen-2018 | Petrioli, R.; Francini, E.; Cherri, S.; Torre, P.; Fiaschi, A. I.; Miano, S. T.; Marrelli, D.; Rovello, F.; Francini, G. | - | |
| CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab | 1-gen-2012 | Petrioli, Roberto; Licchetta, A.; Roviello, Franco; Pascucci, A.; Francini, E.; Bargagli, G.; Conca, R.; Miano, S. T.; Marzocca, G.; Francini, Guido; Multidisciplinary Oncology Group on Gastrointestinal, Tumors; Savelli, Vinno | - | |
| Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials | 1-gen-2001 | Klijn, J. G. M.; Blamey, R. W.; Boccardo, F.; Tominaga, T.; Duchateau, L.; Sylvester, R.; Beex, L. V. A. M.; Mauriac, L.; Van Zijl, J. A.; Veyret, C.; Wildiers, J.; Jassem, J.; Piccart, M.; Burghouts, J.; Becqaert, D.; Seynaeve, C.; Mignolet, F.; Duchateau, L.; Sylvester, R.; Namer, M.; Julien, J. P.; Garcia Conde, J.; Dunser, M.; Margreiter, R.; Tjabbes, T.; Roozendaal, K. J.; Van der Velden, P. C.; Nortier, J. W. R.; Blamey, R.; Howell, A.; Forbes, J.; Kaufmann, M.; Nordenskjold, B.; Kvinnsland, S.; Wilson, R. G.; Jonat, W.; Kleeberg, U. R.; Eiermann, W.; Hilfrich, J.; Weitzel, H. K.; Glas, U.; Rutqvist, L. E.; Rudenstam, C.; Sander, S.; Ryden, S.; Honsson, P.; Lonning, P. E.; Loven, L.; Russell, I. S.; Olweny, C.; Byrne, J. J.; Snyder, R. D.; Coates, A. S.; Lowenthal, R. M.; Jeal, P. N.; Dalley, D. N.; Janicke, F.; Kleine, W.; Michel, R. Th.; Canobbio, L.; Amoroso, D.; Rubagotti, A.; Bumma, C.; D'Aprile, M.; De Matteis, A.; Di Carlo, A.; Francini, G.; Petrioli, R.; Folco, U.; Calligioni, E.; Gallotti, P.; Lopez, M.; Mesiti, M.; Pacini, P.; Sassi, M.; Sismondi, P.; Zola, P.; Ogita, M.; Okazaki, M.; Watanabe, T.; Satomi, T.; Hatazawa, C.; Okuyama, N.; Koyama, T.; Kobayashi, M.; Shimizu, T.; Tabei, T.; Sano, M.; Makino, H.; Ando, J.; Kimura, M.; Takeuchi, T.; Aoyama, H.; Koyama, H.; Shin, E.; Chou, G. | - | |
| Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinoma | 1-gen-2024 | Micheletti, Giorgio; Ricchiuti, Vincenzo; Carbone, Ludovico; La Francesca, Noemi; Petrioli, Roberto; Marrelli, Daniele | - | |
| Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy | 1-gen-2018 | Petrioli, Roberto; Chirra, Martina; Messuti, Luciana; Fiaschi, Anna Ida; Savelli, Vinno; Martellucci, Ignazio; Francini, Edoardo | - | |
| Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer | 1-gen-1999 | Erlichman, C; O'Connell, M; Kahn, M; Marsoni, S; Torri, V; Tardio, B; Zaniboni, A; Pancera, G; Martignoni, G; Labianca, R; Barni, A; Seitz, Jf; Milan, C; Bedenne, L; Giovannini, M; Letreut, Yp; Skillings, J; Shepard, L; Zee, B; Petrioli, R; Francini, G | - | |
| Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence | 1-gen-2016 | Polom, Karol Roman; Marano, Luigi; Roviello, Giandomenico; Petrioli, Roberto; Piagnerelli, Riccardo; De Franco, Lorenzo Giacinto; Marrelli, Daniele; Roviello, Franco | - | |
| Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer | 1-gen-2020 | Petrioli, Roberto; Francini, Edoardo; Cherri, Sara; Marrelli, Daniele; Roviello, Franco; Fiaschi, Anna Ida; Miano, Salvatora Tindara; Savelli, Vinno; Calomino, Natale; Farsi, Marco; Vernillo, Remo; Francini, Guido | - | |
| Gastric cancer: Current status of lymph node dissection | 1-gen-2016 | Degiuli, Maurizio; De Manzoni, Giovanni; Di Leo, Alberto; D'Ugo, Domenico; Galasso, Erica; Marrelli, Daniele; Petrioli, Roberto; Polom, Karol Roman; Roviello, Franco; Santullo, Francesco; Morino, Mario | - | |
| GEMCITABINE (dFdC), 5-FLUROURACIL (5FU), AND FOLINIC ACID (FA) IN THE TREATMENT OF PATIENTS WITH GASTRO-ENTERIC CARCINOMAS: A CLINICAL AND PHARMACOLOGICAL STUDY. | 1-gen-2000 | Pierpaolo, Correale; Cerretani, Daniela; Maurizia, Clerici; Claudio, Cozzi; Bruni, Giancarlo; Daniele, Pozzessere; Petrioli, Roberto; Marsili, Stefania; Simona, Messinesc; Sabatino, Mananna; Roviello, Franco; Neri, Alessandro; Pinto, Enrico; Giorgi, Giorgio; Francini, Guido | - | |
| Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer | 1-gen-2020 | Petrioli, R.; Torre, P.; Pesola, G.; Paganini, G.; Paolelli, L.; Miano, S. T.; Martellucci, I.; Francini, G.; Francini, E. | - |